Product overview
A paired-compound research blend studied in laboratory models of growth-hormone-releasing pathways. Commonly used together in in-vitro experiments examining secretagogue receptor activity.

$59.99
A paired-compound research blend studied in laboratory models of growth-hormone-releasing pathways. Commonly used together in in-vitro experiments examining secretagogue receptor activity.
Select vial size
Quantity
Research background
CJC-1295 is a growth-hormone-releasing hormone (GHRH) analogue, while ipamorelin is a growth-hormone secretagogue. Together, they are studied for their ability to influence signaling within the growth hormone/IGF-1 axis.
Research has investigated this combination in relation to growth-hormone secretion, metabolic signaling, body composition, and tissue-repair pathways. Much of the research involving the combination remains preclinical, and human evidence for performance or recovery applications is limited.
Research disclaimer
All products are supplied strictly for in-vitro laboratory research, analytical research, or other legitimate scientific research purposes where applicable. Products are not intended for human or veterinary consumption, diagnosis, treatment, prevention, or mitigation of disease. Information presented on this website describes areas investigated in scientific literature and does not constitute medical advice or a claim that any product is safe or effective for a particular use. Research findings may include in-vitro, animal, observational, or limited human studies and should not be interpreted as equivalent to established clinical evidence. Many compounds in the research-peptide field lack sufficient human safety and efficacy data.
A paired-compound research blend studied in laboratory models of growth-hormone-releasing pathways. Commonly used together in in-vitro experiments examining secretagogue receptor activity.
Information is presented for laboratory and analytical context only. Researchers should consult primary scientific literature and applicable institutional protocols.
Quantity: 10mg. Appearance, formula, molecular weight, and storage conditions will be published only when verified product documentation is available.
Lot number, test date, identity, purity, testing laboratory, and COA fields remain intentionally unpopulated until genuine Valora batch documentation is connected.